Medicine and Dentistry
Arm
10%
Biopsy Technique
34%
Bladder
28%
Bladder Cancer
11%
Bleeding
11%
Body Mass Index
7%
Cancer
10%
Cancer Mortality
5%
Cancer Risk
8%
Cancer Screening
7%
Chronic Pelvic Pain Syndrome
17%
Clear Cell Renal Cell Carcinoma
21%
Clinical Trial
6%
Colorectal Cancer Screening
8%
Comorbidity
5%
Cryoablation
6%
Cystalgia
11%
Cystectomy
22%
Diagnosis
8%
Diseases
25%
Dutasteride
13%
Enuresis
6%
Gleason Score
8%
Health Care Cost
6%
Incontinence
8%
Interstitial Cystitis
11%
Ischemia
6%
Kidney Cancer
7%
Kidney Function
7%
Kidney Stone
9%
Kidney Surgery
6%
Kidney Tumour
35%
Laparoscopic Surgery
8%
Logistic Regression Analysis
6%
Lower Urinary Tract Symptom
18%
Lung Cancer Screening
9%
Magnetic Resonance Imaging
11%
Malignant Neoplasm
19%
Meta-Analysis
5%
Metastatic Carcinoma
7%
Minimally Invasive Procedure
5%
Neoplasm
41%
Nephrectomy
10%
Nephroureterectomy
6%
Non Muscle Invasive Bladder Cancer
7%
Obstruction
5%
Odds Ratio
9%
Operation Duration
13%
Ovarian Cancer Screening
9%
Overactive Bladder
7%
Overall Survival
9%
Pain
10%
Partial Nephrectomy
49%
Pediatrics
9%
Pelvis
11%
Pelvis Pain Syndrome
9%
Percutaneous Nephrolithotomy
6%
Placebo
7%
Postoperative Complication
5%
Prostate Biopsy
15%
Prostate Cancer
100%
Prostate Hypertrophy
11%
Prostate Specific Antigen
26%
Prostatectomy
34%
Pyeloplasty
5%
Quality of Life
11%
Radiation Therapy
6%
Radical Nephrectomy
10%
Recurrent Disease
13%
Retroperitoneal Lymph Node Dissection
7%
Robot-Assisted Prostatectomy
7%
Robot-Assisted Surgery
5%
Stress Incontinence
6%
Surgeon
17%
Surgery
13%
Surgical Margin
5%
Surgical Technique
6%
Systematic Review
9%
Transitional Cell Carcinoma
11%
Ureter
8%
Ureteroscopy
8%
Urinary Diversion
5%
Urinary System
17%
Urinary Tract Infection
6%
Urine Incontinence
7%
Urologist
7%
Urology
5%
Keyphrases
5α-reductase Inhibitors
5%
ACK1
9%
Active Surveillance
11%
Androgen Receptor
5%
Benign Prostatic Hyperplasia
14%
Bladder
18%
Bladder Cancer
12%
Bladder Pain Syndrome
14%
Body Mass Index
6%
Chronic Pelvic Pain
10%
Clinical Trials
5%
Colorectal Cancer Screening
10%
Confidence Interval
14%
Digital Rectal Examination
5%
Dutasteride
19%
Estimated Blood Loss
5%
Finasteride
6%
Functional Outcome
5%
Genome-wide Association Study
6%
Hazard Ratio
5%
High-grade Prostate Cancer
6%
Interstitial Cystitis
12%
Kidney
8%
Laparoscopic Partial Nephrectomy
22%
Laparoscopic Radical Prostatectomy
5%
Length of Stay
5%
Lower Urinary Tract Symptoms
21%
Lung Cancer Screening
10%
Magnetic Resonance Imaging
5%
Meta-analysis
5%
Multi-institutional
6%
Multidisciplinary Approach
8%
Multiparametric MRI (mpMRI)
7%
Multivariable
6%
Network Studies
7%
Non-muscle Invasive Bladder Cancer (NMIBC)
8%
Obesity
5%
Odds Ratio
11%
Oncological Outcomes
10%
Operative Time
9%
Ovarian Cancer Screening
11%
Overactive Bladder Symptom Score (OABSS)
11%
Overall Survival
8%
Partial Nephrectomy
12%
Patient Selection
5%
Percutaneous Nephrolithotomy
5%
Placebo
7%
Porcine Model
7%
Postoperative Complications
5%
Postoperative Outcomes
12%
Prostate
18%
Prostate Biopsy
11%
Prostate Cancer
81%
Prostate Cancer Risk
23%
Prostate Cancer Screening
22%
Prostate Volume
5%
Prostate-specific Antigen
20%
Prostate-specific Antigen Level
6%
Prostate-specific Antigen Testing
5%
Quality of Life
6%
Radical Cystectomy
14%
Radical Nephrectomy
7%
Radical Prostatectomy
20%
Renal Cell Carcinoma
19%
Renal Mass
15%
Renal Tumor
9%
Risk Factors
5%
Robot-assisted Partial Nephrectomy
18%
Robot-assisted Radical Cystectomy
7%
Robot-assisted Radical Prostatectomy
6%
Robotic Partial Nephrectomy
12%
Robotics
7%
Small Renal Mass
12%
Stress Urinary Incontinence
5%
Surgeons
11%
Total Prostate-specific Antigen
8%
Tumor
18%
Tumor Size
7%
United States
6%
Upper Tract Urothelial Carcinoma
8%
Ureter
8%
Ureteroscopy
6%
Urinary Incontinence
6%
Urinary Symptoms
7%
Urinary Tract Infection
5%
Urologic
6%
Urologic Chronic Pelvic Pain Syndrome
17%
Urologists
6%